Clinical Trials
33 trialsFasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
Case Comprehensive Cancer Center
retroESGO ov1
European Society of Gynaecological Oncology
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer
Assiut University
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC
RenJi Hospital
PROBEAT
Women's Hospital School Of Medicine Zhejiang University
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
Obstetrics & Gynecology Hospital of Fudan University
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
Shanghai Gynecologic Oncology Group
HRCC1
Azienda Policlinico Umberto I
CNCMT
Hubei Cancer Hospital
CRS/HIPEC
Mercy Medical Center
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Assiut University
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Sichuan Cancer Hospital and Research Institute
Neoadjuvant Chemotherapy in Cervical Cancer
Banaras Hindu University
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Professor Fernando Figueira Integral Medicine Institute
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
University of Kentucky
SCORPION
Catholic University of the Sacred Heart
FOCUS
Shanghai Gynecologic Oncology Group
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
NACTcervix
Tata Memorial Hospital
Combination Chemotherapy in Treating Patients With Sarcoma
Mayo Clinic
EHNPCTASEOC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer
Asan Medical Center
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer
Japan Clinical Oncology Group
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Japan Clinical Oncology Group
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
European Organisation for Research and Treatment of Cancer - EORTC
The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer
Capital Medical University
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
National Cancer Institute (NCI)
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
PRIMOVAR-1
University Hospital, Bonn